Charting New Paths in Uncontrolled Asthma: Expanding Access to Quality Care

Upon completion of this activity, participants will: Recognize the long-term burden of uncontrolled asthma Analyze the efficacy of biologics in reducing asthma exacerbations in patients with moderate to severe asthma Evaluate the relationship between asthma phenotypes and disease severity to guide personalized treatment recommendations Assess asthma severity to support appropriate referral Identify patients who could benefit from biologic therapy for moderate to severe asthma.